TRVI
Trevi Therapeutics Inc

1,817
Mkt Cap
$1.34B
Volume
1.68M
52W High
$14.39
52W Low
$3.47
PE Ratio
-28.06
TRVI Fundamentals
Price
$10.42
Prev Close
$10.48
Open
$10.27
50D MA
$12.08
Beta
0.72
Avg. Volume
2.1M
EPS (Annual)
-$0.4698
P/B
7.04
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Trevi Therapeutics (NASDAQ:TRVI) Stock Price Down 6.3% - Here's Why
Trevi Therapeutics (NASDAQ:TRVI) Shares Down 6.3% - Here's Why...
MarketBeat·18d ago
News Placeholder
More News
News Placeholder
Flputnam Investment Management Co. Raises Stock Holdings in Trevi Therapeutics, Inc. $TRVI
Flputnam Investment Management Co. grew its stake in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) by 1,105.4% during the third quarter, according to the company in its most recent...
MarketBeat·1mo ago
News Placeholder
Trevi Therapeutics (NASDAQ:TRVI) Trading 5.7% Higher - Time to Buy?
Trevi Therapeutics (NASDAQ:TRVI) Stock Price Up 5.7% - Should You Buy...
MarketBeat·1mo ago
News Placeholder
Trevi Therapeutics, Inc. $TRVI Shares Acquired by Vivo Capital LLC
Vivo Capital LLC grew its stake in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) by 28.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·1mo ago
News Placeholder
226,381 Shares in Trevi Therapeutics, Inc. $TRVI Bought by Prudential Financial Inc.
Prudential Financial Inc. bought a new stake in Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·1mo ago
News Placeholder
Trevi Therapeutics, Inc. $TRVI Shares Purchased by Geode Capital Management LLC
Geode Capital Management LLC boosted its stake in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) by 10.6% in the 2nd quarter, according to the company in its most recent disclosure...
MarketBeat·2mo ago
News Placeholder
Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer
Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer PR Newswire NEW HAVEN...
PR Newswire·2mo ago
News Placeholder
Trevi Therapeutics (NASDAQ:TRVI) Sets New 52-Week High - Still a Buy?
Trevi Therapeutics (NASDAQ:TRVI) Sets New 12-Month High - Here's What Happened...
MarketBeat·2mo ago
News Placeholder
AXQ Capital LP Invests $227,000 in Trevi Therapeutics, Inc. $TRVI
AXQ Capital LP bought a new stake in Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·2mo ago
News Placeholder
MAI Capital Management Sells 537,497 Shares of Trevi Therapeutics, Inc. $TRVI
MAI Capital Management trimmed its holdings in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) by 38.8% in the 2nd quarter, according to the company in its most recent disclosure with...
MarketBeat·2mo ago
<
1
2
...
>

Latest TRVI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.